Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergy to bumblebee venom.

C Bucher1, P Korner, B Wüthrich

  • 1Allergy Unit, Department of Dermatology, University Hospital, Zürich, Switzerland. chbucher@derm.unizh.ch

Current Opinion in Allergy and Clinical Immunology
|April 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microsporidiosis in a solid organ transplant recipient.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2021
Same author

Allergic and intolerance reactions to wine.

Allergologie select·2019
Same author

Impact of drains on nausea and vomiting after thyroid and parathyroid surgery: a randomized controlled trial.

Langenbeck's archives of surgery·2019
Same author

Letter to the Editor: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

The Atopic March.

Allergy·2018
Same author

Combination therapy for multidrug-resistant cytomegalovirus disease.

Transplant infectious disease : an official journal of the Transplantation Society·2015
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Bumblebee venom allergy is rising due to increased greenhouse use. While honeybee venom immunotherapy may offer some protection, pure bumblebee venom immunotherapy is the preferred treatment for most patients.

Area of Science:

  • Allergy and Immunology
  • Toxicology

Background:

  • Bumblebee venom allergy, a rare Hymenoptera venom allergy, is increasing due to the use of bumblebees for greenhouse pollination.
  • Clinical presentation, diagnosis, and therapy for bumblebee venom allergy mirror other Hymenoptera venom allergies.
  • Immunological cross-reactivity exists between bumblebee and honeybee venom.

Purpose of the Study:

  • To evaluate the efficacy and safety of bumblebee venom immunotherapy versus honeybee venom immunotherapy.
  • To investigate the immunological cross-reactivity between bumblebee and honeybee venom.
  • To determine the optimal treatment strategy for bumblebee venom allergy.

Main Methods:

  • Review of clinical presentations, diagnostic methods, and therapeutic approaches for bumblebee venom allergy.

Related Experiment Videos

  • Analysis of immunological cross-reactivity studies between bumblebee and honeybee venom.
  • Case study review of patients undergoing immunotherapy with either honeybee or bumblebee venom.

    • Main Results:

    • Immunotherapy with honeybee venom has shown variable success in protecting against bumblebee venom allergy.
    • Specific IgE antibodies to bumblebee venom may lack cross-reactivity with honeybee venom.
    • Pure bumblebee venom immunotherapy is effective and safe, representing the current treatment of choice.

    Conclusions:

    • Pure bumblebee venom immunotherapy is the recommended treatment for individuals allergic to bumblebee venom who cannot avoid exposure.
    • Honeybee venom immunotherapy may be considered for severe bumblebee sting reactions with concurrent honeybee venom sensitization.
    • Further research is needed to fully elucidate cross-reactivity and optimize immunotherapy protocols.